These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 21274390)
1. A review of new atypical antipsychotic launches in the United States. Ventimiglia J; Kalali AH; Citrome L Psychiatry (Edgmont); 2010 Dec; 7(12):13-5. PubMed ID: 21274390 [TBL] [Abstract][Full Text] [Related]
2. Iloperidone, asenapine and lurasidone: a primer on their current status. Tarazi FI; Stahl SM Expert Opin Pharmacother; 2012 Sep; 13(13):1911-22. PubMed ID: 22849428 [TBL] [Abstract][Full Text] [Related]
3. Asenapine, iloperidone and lurasidone exposures in young children reported to U.S. poison centers. Stassinos G; Klein-Schwartz W Clin Toxicol (Phila); 2018 May; 56(5):355-359. PubMed ID: 28992737 [TBL] [Abstract][Full Text] [Related]
4. Iloperidone, asenapine, and lurasidone: a brief overview of 3 new second-generation antipsychotics. Citrome L Postgrad Med; 2011 Mar; 123(2):153-62. PubMed ID: 21474903 [TBL] [Abstract][Full Text] [Related]
5. Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis. Demyttenaere K; Detraux J; Racagni G; Vansteelandt K CNS Drugs; 2019 Jun; 33(6):549-566. PubMed ID: 31065941 [TBL] [Abstract][Full Text] [Related]
6. Update on newer antipsychotic drugs. Howland RH J Psychosoc Nurs Ment Health Serv; 2011 Apr; 49(4):13-5. PubMed ID: 21446639 [TBL] [Abstract][Full Text] [Related]
7. Asenapine, blonanserin, iloperidone, lurasidone, and sertindole: distinctive clinical characteristics of 5 novel atypical antipsychotics. Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU Clin Neuropharmacol; 2013; 36(6):223-38. PubMed ID: 24201235 [TBL] [Abstract][Full Text] [Related]
8. Asenapine: a clinical review of a second-generation antipsychotic. Stoner SC; Pace HA Clin Ther; 2012 May; 34(5):1023-40. PubMed ID: 22494521 [TBL] [Abstract][Full Text] [Related]
9. Iloperidone: a new benzisoxazole atypical antipsychotic drug. Is it novel enough to impact the crowded atypical antipsychotic market? Albers LJ; Musenga A; Raggi MA Expert Opin Investig Drugs; 2008 Jan; 17(1):61-75. PubMed ID: 18095919 [TBL] [Abstract][Full Text] [Related]
10. Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic. Citrome L Int J Clin Pract; 2009 Aug; 63(8):1237-48. PubMed ID: 19624791 [TBL] [Abstract][Full Text] [Related]
12. Asenapine (Saphris®): GC-MS method validation and the postmortem distribution of a new atypical antipsychotic medication. Miller C; Pleitez O; Anderson D; Mertens-Maxham D; Wade N J Anal Toxicol; 2013 Oct; 37(8):559-64. PubMed ID: 24009049 [TBL] [Abstract][Full Text] [Related]
13. Asenapine: a review of acute and extension phase data in bipolar disorder. McIntyre RS CNS Neurosci Ther; 2011 Dec; 17(6):645-8. PubMed ID: 20950326 [TBL] [Abstract][Full Text] [Related]
14. An assessment of iloperidone for the treatment of schizophrenia. Jain KK Expert Opin Investig Drugs; 2000 Dec; 9(12):2935-43. PubMed ID: 11093363 [TBL] [Abstract][Full Text] [Related]
16. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic. Citrome L Int J Clin Pract; 2009 Dec; 63(12):1762-84. PubMed ID: 19840150 [TBL] [Abstract][Full Text] [Related]
17. Asenapine: A Review in Schizophrenia. Plosker GL; Deeks ED CNS Drugs; 2016 Jul; 30(7):655-66. PubMed ID: 27356921 [TBL] [Abstract][Full Text] [Related]
18. Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults. Bobo WV Expert Rev Clin Pharmacol; 2013 Jan; 6(1):61-91. PubMed ID: 23272794 [TBL] [Abstract][Full Text] [Related]
19. Estimating the Impact of Adherence to and Persistence with Atypical Antipsychotic Therapy on Health Care Costs and Risk of Hospitalization. Jiang Y; Ni W Pharmacotherapy; 2015 Sep; 35(9):813-22. PubMed ID: 26406773 [TBL] [Abstract][Full Text] [Related]